Factor XIII is the zymogen of the enzyme responsible for the stabilization of the fibrin gel in the final stage of the blood-clotting process. The enzyme has been shown to modify fibronectin in a reaction that has been associated with fibroblasts and wound healing (Keski-Oja et al., 1976) . Human plasma FactorXIII consists of two different subunits arranged as a tetramer of composition a2b2 (Schwartz et al., 1973; Cooke & Holbrook, 1974b) . Thrombin cleaves a 36-residue peptide from each a-subunit and converts the zymogen into Factor XIIIa (a'b2). Factor XIIIa is, in the presence of Ca2+, the active enzyme and catalyses the cross-linking of fibrin (Doolittle, 1973) . Systematically the enzyme is fibrin-glutaminefibrin-lysine endo-y-glutamyltransferase. The steadystate kinetics of the reaction are consistent with a substituted double-displacement acyl-enzyme mechanism (Chung & Folk, 1972; Curtis et al., 1974) characteristic of a number of endo-y-glutamyltransferases. Examples of this type of enzyme with less restricted substrate specificity have been found in guinea-pig hair follicle, where it cross-links keratin (Asquith et al., 1970; Harding & Rogers, 1972) , the guinea-pig liver (Folk & Chung, 1973 ) and the ox non-hairy epidermis (Buxman & Wuepper, 1976) . The enzymes found in blood platelets, the placenta and the uterus, like plasma Factor XIII, exist in zymogen form and require activation by thrombin. All of the glutamyltransferases are absolutely dependent on Ca2+ for their activity and have a Km for Ca2+ less than 1 mm [see the review by Folk & Chung (1973) and also Buxman & Wuepper (1976) and Cooke (1974) ]. Plasma Factor XILIa is an Abbreviation used: dansyl, 5-dimethylaminonaphthalene-1-sulphonyl. Vol. 169 exception to the above generalization in that many of its properties, such as the presence of a lag phase in the protein assay , the dissociation and precipitation of a'-subunits (Cooke & Holbrook, 1974b) , the activity in a smallsubstrate assay (Stenberg et al., 1975) and the appearance of thiol-group reactivity , respond to Ca2+ concentrations well above 1 mm, sometimes as high as 50mM. This unique and complex dependence on Ca2+ correlates with the unique occurrence in the plasma Factor XIII of b-subunits (Cooke, i974 Human plasma Factor XIII was isolated from Cohn-I paste essentially as described by Cooke & Holbrook (1974b) . To suppress the generation of large amounts of Factor XIIIa we introduced two modifications which kept the proportion of Factor XIIIa below 3 %: (i) the Cohn-I paste was dissolved in 0.5 M-KCl/50mM-Tris/lOmM-EDTA/1 mM-phenylmethanesulphonyl fluoride adjusted to pH7.5 with 1OM-HCI. The sulphonyl fluoride was used to inhibit any residual trace of serine proteinases [see Magnusson (1974) (Esnouf et al., 1973) , was introduced in an attempt to remove traces of these two zymogens and did not affect the specific activity of the Factor XIII, which remained in the supernatant.
Factor XIII from cow plasma was prepared by the method of Takagi & Konishi (1972) . Factor XIII from pig plasma was prepared by the same method except that the DEAE-cellulose column was equilibrated in a buffer of lower ionic strength (0.02M-Tris/1 niM-EDTA adjusted to pH7.5 with lOM-HCI).
Factor XIIIa was prepared by incubation of Factor XIII with thrombin (10 N.I.H. units/ml) at room temperature for 20min. The activated enzyme was stored at 0°C for up to 8 h without loss of activity.
b2-Protein was prepared from Factor XIIIa (20mg/ ml) by incubation with 33mM-CaCl2 in 0.1M-Tris, adjusted to pH7.5 with 1OM-HCI, overnight at room temperature. The white precipitate containing a'-subunits was removed by centrifugation at 12000g for 10min. CaCl2 was removed from the supernatant containing b2-protein by passage through a column (1 cm x 30cm) of Sephadex G-50 (coarse grade) equilibrated in 0.1 M-Tris/HCI buffer, pH7.5 (in the protein fluorescence experiments), or by dialysis for 24h against 3x3Ovol. of the same buffer (in the equilibrium-dialysis experiments). Factor-XIIIa activity was assayed by the method described by Cooke & Holbrook (1974a) , which continuously measures the increase in fluorescence as dansylcadaverine is incorporated into dephosphosphorylated acetylated f-casein in the presence of 5mM-CaCl2. One unit of enzyme activity is the amount of enzyme that gives 1 % increase in the starting fluorescence/min at 25°C. In some experiments CaCl2 was omitted from the assay medium and replaced by chlorides of various other metals.
The dansyl-cadaverine incorporated into casein in the presence of Factor XIIIa was directly measured: the fluorescence assay was stopped after 5min by the addition of trichloroacetic acid to a final concentration of 15% (w/v). The cuvette contents were centrifuged at 1000g for 5min and the protein precipitate was washed with 4 x5ml of 6% trichloroacetic acid. The washed precipitate was dissolved in 5ml of 1 % sodium dodecyl sulphate in 0.1 M-Tris/HCl buffer, pH7.5. The dansyl fluorescence was measured with reference to standard solutions of 10pM-and 5uM-dansyl-cadaverine. The trace fluorescences of controls in which Factor XIIIa was replaced by the zymogen Factor XIII were subtracted.
In the presence of 5mM-CaCl2, 7.5 fluorescence units of Factor XIIIa catalysed the incorporation of 30nmol of dansyl-cadaverine into casein/min, i.e. 1 fluorescence unit of Factor XIIIa represents the amount of enzyme that catalyses incorporation of 4nmol of dansyl-cadaverine/min.
Equilibrium dialysis
All solutions were prepared in distilled de-ionized water. CaCl2 solutions (10uM-3mM) containing a constant proportion (66,M) of "CaCl2 were prepared in 0.1 M-Tris/HCl buffer, pH7.5, and stored in polythene bottles at 4°C. Protein solutions (9-20mg/ ml), routinely stored in the presence of 2mM-EDTA, were dialysed overnight against 0.1 M-Tris/HCl buffer, pH7.5 (3x3Ovol.), to remove the chelating agent. Visking 36/32 dialysis tubing was boiled in 0.2M-EDTA, washed in deionized distilled water and stored in 0.1M-Tris/HCl buffer, pH7.5. The equilibrium dialysis was carried out in micro-dialysis cells as described by Walsh et al. (1976) . Protein was assayed by the method of Lowry et al. (1951) , with bovine serum albumin as standard. 45Ca radioactivity was assayed by liquid-scintillation spectrometry in toluene-based scintillator (4g of butyl-PBD/litre of toluene).
Protein fluorescence
Measurements were carried out with the dualwavelength titrating spectrophotometer and fluorimeter described by Shore et al. (1975) and we first tried to monitor Ca2+ binding by observing whether there was a change in the tryptophan fluorescence of the protein. Fig. 1 shows a typical experiment in which the protein fluorescence of human Factor XIII (0.2mg/ml) was monitored during titration with CaCI2. A-2 %change was observed, with a dissociation constant for Ca2+ (Kca) of 0.13 mm. The average result obtained from three such experiments was Kca = 0.12mm. We obtained an indistinguishable result when the human Factor XIII was replaced by that from cow. We also investigated the binding of Ni2+ and Mn2+ to human and cow Factor XIII by this technique (Fig. 2) Human Factor XlIIa (in the presence of catalytic amounts of thrombin) was also titrated with Ca2+ (Fig. 3) increased beyond 1 mm, to avoid the light-scattering problems from the protein aggregation known to occur at high Ca2+ concentrations (Cooke & Holbrook, 1974b) . Under conditions similar to those above, Ca2+ did not affect the protein fluorescence of b2-protein (Fig. 3) . This result is consistent with the suggestion that it is the a-and not the b-subunits that change their fluorescence in 0.2mM-Ca2+.
Direct Ca2+ binding by equilibrium dialysis
The results of equilibrium dialysis of Factor XIII, Factor XIIIa (in the presence of thrombin) and of b2-subunits against 45CaC12 in micro-dialysis cells are presented in Fig. 4 . Recovery of 45Ca radioactivity at the end of the experiment was always over 90 % and of protein was over 95 %. The results are less precise than those obtained by using protein fluorescence, yet they clearly demonstrate the saturation of tight Ca2+-binding sites in the same range of Ca2+ concentrations that perturb the protein fluorescence. We have also attempted to detect much weaker Ca2+ binding, and indeed at 2.5mM-free Ca2+ the bound Ca2+ increased to about 8 ions/molecule. Whether this weak binding is competition of Ca2+ for non-specific cation-binding sites, or whether it reflects occupancy of those sites that give rise to 'high'-Ca2+ effects, or both, is open to speculation. The binding curve reaches a plateau when each molecule of Factor XIII binds 1.2-1.5 atoms of Ca2 . At the low Ca2+ concentrations that we studied, no binding of Ca2+ to b-subunits could be measured. At low Ca2+ concentrations both Factor XIII and Factor XlIIa bound similar amounts of Ca2 .
Replacement ofthe Ca2+ cofactor by other metal ions
The results of experiments in which Ca2+ ions were replaced by other metals in the fluorescence assay are summarized in Table 1 . A wide range of metal ions (both bi-and ter-valent) can to some extent replace Ca2+ ions as cofactor for Factor XlIIa activity. It was possible that fluorescence artifacts could affect the measured rates in the fluorescence assay of activity. At the pH of the assay (7.5) there was precipitation ofcasein in the presence of some metals. This was not a serious problem in most cases, and even when it took place the double-beam instrument automatically corrected for the scattering (Cooke & Holbrook, 1974a) . With Cr3+, Ce3+, Al3+ (and Tb3+ at concentrations over 1.25mM), the precipitation was too heavy to allow any fluorescence measurements. No relative fluorescence change was observed in control experiments in which (a) Factor XIIIa was omitted from the assay or (b) Factor XIII was included in the assay but the thrombin required for activation was omitted, and we conclude that the changes in fluorescence that we observed reflected enzyme activity. This was confirmed for Tb3+ by measurement of 32nmol of dansyl-cadaverine covalently bound to casein after exposure to Factor XIIIa (7.5 units at optimum conditions, i.e. 5mM-Ca2+) in the presence of 0.5mM-Tb3+ for 5min. Although we have no reason to doubt that Ca2+ is the normal physiological cofactor for Factor XIIIa, it was interesting to observe the apparently low specificity of the enzyme from three different sources (human, cow and pig) with respect to metal ions. Such comparisons of the properties of an enzyme from different sources are useful, as the comparison should reveal which properties of the human enzyme are fundamental to its biological role and which are species-specific details ofdoubtful general significance.
